147 related articles for article (PubMed ID: 15913998)
1. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs.
Nakagawa-Goto K; Bastow KF; Wu JH; Tokuda H; Lee KH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3016-9. PubMed ID: 15913998
[TBL] [Abstract][Full Text] [Related]
2. Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs.
Nakagawa-Goto K; Chen TH; Peng CY; Bastow KF; Wu JH; Lee KH
J Med Chem; 2007 Jul; 50(14):3354-8. PubMed ID: 17569518
[TBL] [Abstract][Full Text] [Related]
3. Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives.
Nakagawa-Goto K; Wu JH; Bastow KF; Wu CC; Lee KH
Bioorg Med Chem; 2005 Mar; 13(6):2325-30. PubMed ID: 15727881
[TBL] [Abstract][Full Text] [Related]
4. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antitumor activity of desmosdumotin C analogues.
Wen BY; Liang H; Guo HJ; Wu JH
J Asian Nat Prod Res; 2019 Jul; 21(7):702-715. PubMed ID: 30596267
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship of novel semi-synthetic flavonoids as antiproliferative agents.
Ragab FA; Yahya TA; El-Naa MM; Arafa RK
Eur J Med Chem; 2014 Jul; 82():506-20. PubMed ID: 24937184
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analogues.
Nakagawa-Goto K; Chang PC; Lai CY; Hung HY; Chen TH; Wu PC; Zhu H; Sedykh A; Bastow KF; Lee KH
J Med Chem; 2010 Sep; 53(18):6699-705. PubMed ID: 20735140
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents 283. Further elaboration of desmosdumotin C analogs as potent antitumor agents: activation of spindle assembly checkpoint as possible mode of action.
Nakagawa-Goto K; Wu PC; Bastow KF; Yang SC; Yu SL; Chen HY; Lin JC; Goto M; Morris-Natschke SL; Yang PC; Lee KH
Bioorg Med Chem; 2011 Mar; 19(5):1816-22. PubMed ID: 21296579
[TBL] [Abstract][Full Text] [Related]
9. First total synthesis of protoapigenone and its analogues as potent cytotoxic agents.
Lin AS; Nakagawa-Goto K; Chang FR; Yu D; Morris-Natschke SL; Wu CC; Chen SL; Wu YC; Lee KH
J Med Chem; 2007 Aug; 50(16):3921-7. PubMed ID: 17622129
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines.
Cárdenas M; Marder M; Blank VC; Roguin LP
Bioorg Med Chem; 2006 May; 14(9):2966-71. PubMed ID: 16412650
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative activity of α-branched α,β-unsaturated ketones.
Karpaviciene I; Cikotiene I; Padrón JM
Eur J Med Chem; 2013; 70():568-78. PubMed ID: 24211632
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Anti-cancer Activity of Novel Thiazolidinone Analogs of 6-Aminoflavone.
Moorkoth S
Chem Pharm Bull (Tokyo); 2015; 63(12):974-85. PubMed ID: 26369709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative in-vitro activity of natural flavans and related compounds.
Zhang L; Zhang WG; Ma EL; Wu L; Bao K; Wang XL; Wang YL; Song HR
Arch Pharm (Weinheim); 2007 Dec; 340(12):650-5. PubMed ID: 17994602
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity evaluation of chrysin derivatives.
Zhu ZY; Wang WX; Wang ZQ; Chen LJ; Zhang JY; Liu XC; Wu SP; Zhang YM
Eur J Med Chem; 2014 Mar; 75():297-300. PubMed ID: 24556144
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
[TBL] [Abstract][Full Text] [Related]
16. Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells.
Orlikova B; Menezes JC; Ji S; Kamat SP; Cavaleiro JA; Diederich M
Eur J Med Chem; 2014 Sep; 84():173-80. PubMed ID: 25016375
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
Fu W; Wang J; Yu L; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2012 Jan; 22(2):1118-21. PubMed ID: 22196122
[TBL] [Abstract][Full Text] [Related]
18. Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.
Arai MA; Utsumi T; Yanase N; Fujimatsu T; Ishibashi M
Chem Pharm Bull (Tokyo); 2017; 65(8):784-795. PubMed ID: 28768932
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cancer cell growth inhibitory activity of icaritin derivatives.
Wang C; Wu P; Shi JF; Jiang ZH; Wei XY
Eur J Med Chem; 2015 Jul; 100():139-50. PubMed ID: 26079090
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
Xia Y; Yang ZY; Xia P; Bastow KF; Nakanishi Y; Lee KH
Bioorg Med Chem Lett; 2000 Apr; 10(8):699-701. PubMed ID: 10782667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
